300239.SZ
东宝生物
SZSE · Healthcare · C 制造业 · CN
CNY 4.98
−5.50%Aug 30, 2026, 15:08 UTC
Dongbao Bio, a subsidiary of Guoen Co., Ltd., reported its 2026 semi-annual results: revenue of 415 million yuan, up 12.37% year-on-year; net profit of 37.404 million yuan, up 1.18% year-on-year.
Source: